Cytogenetic findings and clinical features in acute leukemia and transient myeloproliferative disorder in Down's syndrome

Blood. 1988 Jul;72(1):15-23.

Abstract

Cytogenetic, immunologic, and electron microscopic studies were performed on the blast cells of 28 pediatric patients with Down's syndrome, 13 with acute leukemia (DS-AL) and 15 with transient myeloproliferative disorders (DS-TMD). Clonal chromosome abnormalities were found in the cells of all patients with DS-AL but not those with DS-TMD. The younger ages and higher hemoglobin concentrations, platelet counts, and WBC counts of DS-TMD patients provided a clinical contrast with the frankly leukemic cases. Myelodysplastic syndrome, characterized by a small percentage of leukemic blast cells, was observed in 11 of the 13 patients with DS-AL compared with none in the DS-TMD group. Electron microscopy disclosed a positive platelet peroxidase reaction in each of the 11 DS-TMD patients and in nine of the 13 DS-AL patients. Immunologic studies revealed antiplatelet-megakaryocyte antigens on the blast cells of the majority of patients in both study groups. Our findings suggest that the blast cells in cases of DS-AL and DS-TMD arise from cells of the megakaryocytic lineage or from a myeloid progenitor with the capacity for megakaryocytic differentiation. The high risk of the development of AL in patients with DS who are less than 3 years old may be related to increased megakaryocyte proliferation in this age group.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Antibodies, Monoclonal
  • Blood Cells / ultrastructure
  • Bone Marrow / ultrastructure
  • Child, Preschool
  • Cytogenetics*
  • Down Syndrome / blood
  • Down Syndrome / genetics*
  • Down Syndrome / pathology
  • Female
  • Humans
  • Immunohistochemistry
  • Infant
  • Infant, Newborn
  • Leukemia / blood
  • Leukemia / genetics*
  • Leukemia / pathology
  • Male
  • Microscopy, Electron
  • Myeloproliferative Disorders / blood
  • Myeloproliferative Disorders / genetics*
  • Myeloproliferative Disorders / pathology

Substances

  • Antibodies, Monoclonal